MedWatch

Sweden phases out AstraZeneca's covid-19 vaccine

89 percent of the Swedish population above the age of 65 are fully vaccinated, meaning authorities in Sweden are phasing out the use of the AstraZeneca vaccine. In Stockholm, residents now have a choice of vaccines.

Photo: Dado Ruvic/REUTERS / X02714

The coronavirus vaccine produced by AstraZeneca is gradually being phased out in Sweden.

On Friday, the Swedish health authorities announced that 89 percent of people of above the age group 65, the main recipients of this vaccine in Sweden, are now fully vaccinated.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs